These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Safety and efficacy of long-term co-administration of fenofibrate and ezetimibe in patients with mixed hyperlipidemia. McKenney JM; Farnier M; Lo KW; Bays HE; Perevozkaya I; Carlson G; Davies MJ; Mitchel YB; Gumbiner B J Am Coll Cardiol; 2006 Apr; 47(8):1584-7. PubMed ID: 16630994 [TBL] [Abstract][Full Text] [Related]
3. An evaluation of alanine transaminase and creatine kinase elevations with the use of ezetimibe in an ambulatory care setting. McGinnis B; Schimmer J; Hutka K J Clin Lipidol; 2010; 4(6):501-7. PubMed ID: 21122697 [TBL] [Abstract][Full Text] [Related]
4. Ezetimibe/simvastatin (INEGY) in the treatment of hyperlipidaemia. Kastelein JJ; Sankatsing RR Int J Clin Pract; 2005 Dec; 59(12):1464-71. PubMed ID: 16351680 [TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of the coadministration of ezetimibe/simvastatin with fenofibrate in patients with mixed hyperlipidemia. Farnier M; Roth E; Gil-Extremera B; Mendez GF; Macdonell G; Hamlin C; Perevozskaya I; Davies MJ; Kush D; Mitchel YB; Am Heart J; 2007 Feb; 153(2):335.e1-8. PubMed ID: 17239698 [TBL] [Abstract][Full Text] [Related]
6. Letter by Westerink and Visseren regarding article, "Evidence for statin pleiotropy in humans: differential effects of statins and ezetimibe on rho-associated coiled-coil containing protein kinase activity, endothelial function, and inflammation". Westerink J; Visseren FL Circulation; 2009 Sep; 120(9):e66; author reply e69-70. PubMed ID: 19720942 [No Abstract] [Full Text] [Related]
7. Letter by Settergren et al regarding article, "Evidence for statin pleiotropy in humans: differential effects of statins and ezetimibe on rho-associated coiled-coil containing protein kinase activity, endothelial function, and inflammation". Settergren M; Rydén L; Pernow J Circulation; 2009 Sep; 120(9):e68; author reply e69-70. PubMed ID: 19720944 [No Abstract] [Full Text] [Related]
8. Ezetimibe in the treatment of uncontrolled hyperlipidemia in kidney transplant patients. Rodríguez-Ferrero ML; Anaya F Transplant Proc; 2008 Dec; 40(10):3492-5. PubMed ID: 19100421 [TBL] [Abstract][Full Text] [Related]
9. Letter by Tershakovec et al regarding article, "Evidence for statin pleiotropy in humans: differential effects of statins and ezetimibe on rho-associated coiled-coil containing protein kinase activity, endothelial function, and inflammation". Tershakovec AM; Veltri EP; Pasternak RC Circulation; 2009 Sep; 120(9):e67; author reply e69-70. PubMed ID: 19720943 [No Abstract] [Full Text] [Related]
11. Lowering low-density lipoprotein cholesterol: statins, ezetimibe, bile acid sequestrants, and combinations: comparative efficacy and safety. Hou R; Goldberg AC Endocrinol Metab Clin North Am; 2009 Mar; 38(1):79-97. PubMed ID: 19217513 [TBL] [Abstract][Full Text] [Related]
12. Setting a new standard in achieving superior efficacy: ezetimibe + simvastatin. Farnier M Fundam Clin Pharmacol; 2007 Nov; 21 Suppl 2():27-8. PubMed ID: 18001317 [TBL] [Abstract][Full Text] [Related]
13. Evaluation of the potential for pharmacokinetic interaction between fenofibrate and ezetimibe: A phase I, open-label, multiple-dose, three-period crossover study in healthy subjects. Gustavson LE; Schweitzer SM; Burt DA; Achari R; Rieser MJ; Edeki T; Chira T; Yannicelli HD; Kelly MT Clin Ther; 2006 Mar; 28(3):373-87. PubMed ID: 16750452 [TBL] [Abstract][Full Text] [Related]
14. The antilipidemic effects of ezetimibe in patients with diabetes. Stroup JS; Kane MP; Busch RS Diabetes Care; 2003 Oct; 26(10):2958-9. PubMed ID: 14514611 [No Abstract] [Full Text] [Related]